ANAPC15P2

Across TCGA pan-cancer cohorts, ANAPC15P2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated ANAPC15P2 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher ANAPC15P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ANAPC15P2 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

THCA, KIRC, and DLBC are the cancer types where ANAPC15P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.905	0.979	<.001	69	view →
KIRC	DFS	Tertile	All	0.517	0.666	.001	62	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	45	view →
CESC	OS	Tertile	III,IV	0.260	0.689	.005	42	view →
PAAD	DFS	Tertile	All	0.162	0.476	.001	36	view →
LIHC	OS	Tertile	II,III,IV	0.302	0.626	.008	27	view →
LUAD	OS	Tertile	All	0.201	0.673	.003	18	view →
STAD	DFS	Tertile	III,IV	0.412	0.660	.015	13	view →
SKCM	OS	Tertile	II,III,IV	0.713	0.855	.016	12	view →
UCEC	OS	Tertile	IV	0.977	0.646	.016	12	view →
PRAD	OS	Tertile	All	0.974	0.996	.013	12	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

ANAPC15P2–THCA (OS)

Open the THCA breakdown →